hsk31679
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Feb 11, 2022 (NCT05531097)
Timeline
Indications
Mechanism of action
- Thyroid hormone receptor beta-1INHIBITOR
THRB inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06258746 | Phase 1 | Dec 5, 2023 | Haisco Pharmaceutical |
| NCT06168383 | Phase 2 | Nov 23, 2023 | Haisco Pharmaceutical |
| NCT05795517 | Phase 2 | Apr 26, 2023 | Haisco Pharmaceutical |
| NCT05531097 | Phase 1 | Feb 11, 2022 | Haisco Pharmaceutical |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Haisco Pharmaceutical | For profit | 4 | 4 | 2 | 2022 |
1 organizations
Page 1 / 1